VTA: FDA CTP's Actions Undermine Public Health

Regulations by 2FIRSTS.ai
Jan.22.2024
VTA: FDA CTP's Actions Undermine Public Health
The US FDA reportedly denies marketing orders for Suorin and blu PLUS+ e-cigarettes, drawing criticism from the VTA.

On January 19th, Tony Abboud, the Executive Director of the Vapor Technology Association (VTA), announced that the U.S. Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Suorin and blu PLUS+ e-cigarettes. This decision by the FDA and the Center for Tobacco Products (CTP) is seen as part of their ongoing efforts to effectively ban e-cigarettes in the United States.

 

Abdullah states that the FDA continually emphasizes that e-cigarette manufacturers have not provided "sufficient scientific evidence" in their PMTA applications. However, the FDA refuses to address the Reagan-Udall Foundation's fundamental criticism of the entire regulatory process, which is that the FDA has not clearly outlined what needs to be proven for something to be considered "appropriate for the protection of public health (APPH)," nor how it interprets what APPH entails.

 

Abdul believes that not objectively defining and using standards to refuse marketing authorization for critical smoking cessation and harm reduction products is a serious overreach for any government agency that follows a scientific mission.

 

The court found that the process had become "arbitrary and capricious" in practice, with CTP leadership determining standards based on specific circumstances. Meanwhile, the company was simply attempting to do the right thing by adhering to the PMTA process established by the FDA.

 

He continued, "Most notably, CTP claims to have denied Suorin's PMTA because its product promotes 'sustained use and progression' of dependence. If this is the standard, then every nicotine product would fail CTP's bizarre criteria, as nicotine is addictive, furthering CTP's implementation of a ban on less harmful nicotine."

 

"The actions taken by the FDA and CTP today do not contribute to the protection of public health or to assisting Americans who smoke. VTA once again urges CTP to reverse its malicious behavior and restore the scientific integrity of its regulatory and decision-making processes. Enough is enough," said Abdu.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Imperial Brands Urges UK Government to Strengthen E-Cigarette Sales Guidelines and Promote Refillable Devices
Imperial Brands Urges UK Government to Strengthen E-Cigarette Sales Guidelines and Promote Refillable Devices
Imperial Brands urges the UK to strengthen e-cigarette sales guidance, supporting pod-only sales compatible with reusable devices. The company says this approach, alongside the disposable vape ban, can better reduce e-waste and improve cost-effectiveness.
Jul.30 by 2FIRSTS.ai
Altria and Reynolds American announce launch of new smokeless tobacco products without FDA approval; anti-smoking advocates express concerns over potential impact on youth health
Altria and Reynolds American announce launch of new smokeless tobacco products without FDA approval; anti-smoking advocates express concerns over potential impact on youth health
Altria and Reynolds American are rolling out smoke-free products without FDA approval due to delays. They highlight that illegal e-cigarettes, with candy flavors, are gaining market share while legal products await approval. Altria will release a new nicotine pouch in select states, and Reynolds will launch a disposable e-cigarette. Advocates fear these unauthorized products may attract new users and harm youth.
Sep.01 by 2FIRSTS.ai
ELURA Founder and Former BAT Design Head Jonathon Lister Speaks at 2Firsts Global NGP Rethink Forum
ELURA Founder and Former BAT Design Head Jonathon Lister Speaks at 2Firsts Global NGP Rethink Forum
ELURA founder and former BAT Head of Product and User Experience Design, Jonathon Lister, delivered a keynote speech titled “Rethinking the Design of Next Generation Tobacco Products” at the 2Firsts Global NGP Rethink Forum in Shenzhen.
Jul.28 by 2FIRSTS.ai
France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026
France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026
France's Decree No. 2025-898 bans all oral nicotine products nationwide six months after publication. Medicines and medical devices are exempt. This includes nicotine pouches, gum, lozenges, and other forms, regardless of origin. The decree is based on the Public Health Code and applies to mainland France and Wallis and Futuna Islands.
Sep.08
Malaysian Prime Minister Announces Plan to Impose Health Tax on Vapes and Related Products
Malaysian Prime Minister Announces Plan to Impose Health Tax on Vapes and Related Products
Malaysian Prime Minister Anwar Ibrahim announced in the Lower House that the health promotion tax, previously limited to sugary drinks, will be expanded to include tobacco, vapes, and alcohol. The Health Ministry expects to generate around $9.4 billion in revenue.
Aug.01 by 2FIRSTS.ai
Kenya Announces a Complete Ban on All Tobacco Product Imports, Health Minister: Public Health Takes Priority
Kenya Announces a Complete Ban on All Tobacco Product Imports, Health Minister: Public Health Takes Priority
Kenya has banned the import of all tobacco products to reduce supply and tackle health issues. The Health Minister emphasized continuing efforts against illegal tobacco smuggling and announced stricter graphic health warnings to protect youth from tobacco harms.
Aug.04 by 2FIRSTS.ai